EUVIMEDEUVIMED entdecken
Open Access

Statin Therapy Reduces Radiation‐Induced Cardiotoxicity in Patients With Breast Cancer Receiving Adjuvant Radiotherapy

Yan-Jiun Huang, Jui-An Lin iD, Wan-Ming Chen iD, Ben-Chang Shia iD, Szu-Yuan Wu iD

Journal of the American Heart Association · 15.10.2024 · 13 (20)

DOI: 10.1161/jaha.124.036411 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 15.10.2024. Verfasst von Yan-Jiun Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Colorectal Surgery, Department of Surgery Taipei Medical University Hospital, Taipei Medical University Taipei Taiwan. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Cardiotoxicity. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To evaluate the efficacy of statin therapy in reducing major adverse cardiovascular event (MACE) risk among patients with breast cancer undergoing breast‐conserving surgery and adjuvant whole breast radiotherapy. Methods and Results A retrospective cohort study was conducted using data from the Taiwan Cancer Registry Database linked to the National Health Insurance Research Database. Patients diagnosed with left‐sided early breast invasive ductal carcinoma between 2016 and 2019 were included. Propensity score matching was employed to compare MACE risk between statin users and nonusers. Cox regression models were used to estimate adjusted hazard ratios (aHRs) for MACE, considering cumulative defined daily doses and daily defined doses of statins. Among 1481 patients undergoing breast‐conserving surgery and adjuvant whole breast radiotherapy, statin use significantly reduced MACE risk (aHR, 0.34 [95% CI, 0.25–0.44]). Hydrophilic statins, particularly rosuvastatin and pravastatin, demonstrated the greatest risk reduction. Higher cumulative defined daily doses and daily intensity doses of statins were associated with lower MACE risk, indicating a dose–response relationship. The 5‐year cumulative incidence of MACE was significantly lower in statin users compared with nonusers (12.24% versus 31.70%).

Conclusions

Statin therapy is associated with a reduced risk of MACE in patients with breast cancer undergoing breast‐conserving surgery and adjuvant whole breast radiotherapy. Hydrophilic statins rosuvastatin and pravastatin exhibit the most pronounced cardioprotective effects. These findings suggest a potential role for statins in mitigating cardiovascular complications in this population and highlight the need for further research to optimize statin therapy in survivors of breast cancer undergoing radiotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsCardiotoxicityHumansFemaleMiddle AgedRetrospective StudiesRadiotherapy, AdjuvantTaiwanAgedBreast NeoplasmsIncidenceMastectomy, SegmentalRegistriesRisk AssessmentRadiation InjuriesAdultCarcinoma, Ductal, BreastRisk FactorsTreatment Outcome

Stichwörter der Autor:innen

breast cancerdose–response relationshipsradiation therapyradiation‐induced MACEstatin therapy

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Division of Colorectal Surgery, Department of Surgery Taipei Medical University Hospital, Taipei Medical University Taipei Taiwan.
  • Department of Surgery, School of Medicine College of Medicine, Taipei Medical University Taipei Taiwan.
  • Division of General Surgery, Department of Surgery Taipei Medical University Hospital, Taipei Medical University Taipei Taiwan.
  • Department of Anesthesiology, School of Medicine Chung Shan Medical University Taichung Taiwan.
  • Department of Anesthesiology Chung Shan Medical University Hospital Taichung Taiwan.
  • Center for Regional Anesthesia and Pain Management Chung Shan Medical University Taichung Taiwan.

ORCID-Profile: Jui-An Lin, Wan-Ming Chen, Ben-Chang Shia, Szu-Yuan Wu

Zitieren

APA

Huang, Y. J., Lin, J. A., Chen, W. M., Shia, B. C., & Wu, S. Y. (2024). Statin Therapy Reduces Radiation‐Induced Cardiotoxicity in Patients With Breast Cancer Receiving Adjuvant Radiotherapy. Journal of the American Heart Association, 13(20). https://doi.org/10.1161/jaha.124.036411

Vancouver

Huang YJ, Lin JA, Chen WM, Shia BC, Wu SY. Statin Therapy Reduces Radiation‐Induced Cardiotoxicity in Patients With Breast Cancer Receiving Adjuvant Radiotherapy. Journal of the American Heart Association. 2024;13(20). doi:10.1161/jaha.124.036411

BibTeX
@article{Huang2024,
  author = {Huang, Yan-Jiun and Lin, Jui-An and Chen, Wan-Ming and Shia, Ben-Chang and Wu, Szu-Yuan},
  title = {Statin Therapy Reduces Radiation‐Induced Cardiotoxicity in Patients With Breast Cancer Receiving Adjuvant Radiotherapy},
  journal = {Journal of the American Heart Association},
  year = {2024},
  volume = {13},
  number = {20},
  doi = {10.1161/jaha.124.036411}
}
Kostenlos starten →